REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 71 filers reported holding REGENXBIO INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,755,172 | -16.5% | 106,634 | +1.4% | 0.00% | 0.0% |
Q2 2023 | $2,101,388 | +107663.5% | 105,122 | +1.9% | 0.00% | 0.0% |
Q1 2023 | $1,950 | -13.8% | 103,146 | +3.4% | 0.00% | -33.3% |
Q4 2022 | $2,263 | -99.9% | 99,782 | -3.8% | 0.00% | -25.0% |
Q3 2022 | $2,740,000 | +13.9% | 103,680 | +6.5% | 0.00% | 0.0% |
Q2 2022 | $2,405,000 | -17.1% | 97,355 | +11.4% | 0.00% | 0.0% |
Q1 2022 | $2,902,000 | +8.2% | 87,427 | +6.6% | 0.00% | +33.3% |
Q4 2021 | $2,681,000 | -24.0% | 81,984 | -2.6% | 0.00% | -40.0% |
Q3 2021 | $3,527,000 | -2.2% | 84,147 | -9.3% | 0.01% | 0.0% |
Q2 2021 | $3,605,000 | +30.5% | 92,781 | +14.5% | 0.01% | +25.0% |
Q1 2021 | $2,763,000 | -14.9% | 81,012 | +13.2% | 0.00% | 0.0% |
Q4 2020 | $3,247,000 | +55.4% | 71,579 | -5.8% | 0.00% | +33.3% |
Q3 2020 | $2,090,000 | -34.5% | 75,958 | -12.3% | 0.00% | -40.0% |
Q2 2020 | $3,190,000 | +7.4% | 86,606 | -5.6% | 0.01% | -16.7% |
Q1 2020 | $2,970,000 | -18.5% | 91,730 | +3.1% | 0.01% | 0.0% |
Q4 2019 | $3,644,000 | +28.8% | 88,934 | +11.9% | 0.01% | +20.0% |
Q3 2019 | $2,830,000 | -31.1% | 79,482 | -0.6% | 0.01% | -37.5% |
Q2 2019 | $4,108,000 | -1.8% | 79,962 | +9.5% | 0.01% | 0.0% |
Q1 2019 | $4,184,000 | +35.1% | 73,009 | -1.1% | 0.01% | +14.3% |
Q4 2018 | $3,096,000 | -27.1% | 73,809 | +31.2% | 0.01% | -12.5% |
Q3 2018 | $4,247,000 | +5.1% | 56,252 | -0.2% | 0.01% | 0.0% |
Q2 2018 | $4,042,000 | +395.3% | 56,338 | +106.1% | 0.01% | +300.0% |
Q1 2018 | $816,000 | -11.2% | 27,336 | -1.1% | 0.00% | 0.0% |
Q4 2017 | $919,000 | +0.9% | 27,651 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $911,000 | +69.3% | 27,651 | +1.5% | 0.00% | +100.0% |
Q2 2017 | $538,000 | +48.6% | 27,251 | +45.5% | 0.00% | 0.0% |
Q1 2017 | $362,000 | +10.0% | 18,731 | +5.6% | 0.00% | 0.0% |
Q4 2016 | $329,000 | +18.3% | 17,733 | -10.7% | 0.00% | 0.0% |
Q3 2016 | $278,000 | +87.8% | 19,858 | +7.3% | 0.00% | – |
Q2 2016 | $148,000 | – | 18,508 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 831,014 | $15,714,475 | 6.51% |
MPM BioImpact LLC | 617,671 | $11,680,159 | 3.03% |
Sonic GP LLC | 193,079 | $3,651,124 | 2.79% |
ArchPoint Investors | 224,278 | $4,241,097 | 1.84% |
Redmile Group, LLC | 1,640,725 | $31,026,110 | 1.35% |
MIRABELLA FINANCIAL SERVICES LLP | 25,983 | $5,461,344 | 0.83% |
WS MANAGEMENT LLLP | 396,997 | $7,507,213 | 0.79% |
Redwood Wealth Management Group, LLC | 15,190 | $287,243 | 0.33% |
SummerHaven Investment Management, LLC | 27,503 | $520,082 | 0.30% |
Lombard Odier Asset Management (Switzerland) SA | 130,369 | $2,465,278 | 0.22% |